Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $5.18-$9.47 |
Market Cap | $3.4B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $2.7B |
Revenue Growth (YoY) | 18.4% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | -$0.38 |
News
See moreYahoo Finance • 6 months ago
Amneal to Report Third Quarter 2024 Results on November 8, 2024
Yahoo Finance • 7 months ago
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
Yahoo Finance • 8 months ago
Amneal Reports Second Quarter 2024 Financial Results
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,300 |
